PrEMeR-CG

PrEMeR-CG infers nucleotide-resolution DNA methylation values from capture-based next-generation sequencing (NGS) data by leveraging library fragment length profiles to provide high-resolution methylation analysis.

Key Features:

• Nucleotide-Resolution Methylation Values: PrEMeR-CG computes nucleotide-resolution methylation estimates by integrating library fragment length profiles into an analytical model.
• Enhanced Predictive Power: The method provides improved predictive performance compared with window-based approaches used for enrichment data by using nucleotide-resolution information.
• Cost-Effective Analysis: PrEMeR-CG derives high-resolution methylation data from capture-based NGS as a cost-effective alternative to whole-genome bisulfite sequencing (WGBS).
• Clinical Applications: The approach has been applied to generate clinically significant gene signatures in acute myeloid leukemia (AML) by integrating nucleotide-resolution methylation with gene expression profiles.
• Statistical Methodology: The package includes a complementary statistical method to detect differentially methylated features from the high-resolution methylation estimates.

Scientific Applications:

• Gene regulation studies: Enables investigation of DNA methylation's role in gene regulation in normal physiology and disease.
• Cancer epigenetics: Supports analysis of pathological states such as cancer, including oncology research.
• Biomarker discovery and clinical signatures: Facilitates discovery of biomarkers and derivation of clinically significant gene signatures in acute myeloid leukemia (AML) via integration with gene expression.
• Large-scale epigenetic studies: Allows cost-effective large-scale methylation profiling using capture-based NGS.

Methodology:

Leverages library fragment/fragment length profiles integrated into an analytical model to infer nucleotide-resolution methylation values and employs a complementary statistical method to detect differentially methylated features.